세계의 디지털 바이오마커 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 구성 요소별, 유형별, 치료 영역별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Type, By Therapeutic Area, By End User, By Region & Competition, 2020-2030F
상품코드:1785150
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 디지털 바이오마커 시장 규모는 2024년에 34억 9,000만 달러로 평가되었고, 예측 기간에서는 2030년까지의 CAGR이 14.88%를 나타내 눈부신 성장이 예상되고 있습니다.
디지털 바이오마커는 디지털 건강 기술을 활용하여 개인이 자신의 건강과 치료에 대해 적극적으로 수집하는 정보를 캡처합니다. 이 정보는 건강 상태의 설명, 영향 및 예측에 사용됩니다. 디지털 바이오마커는 수면 패턴, 심박동 변동, 신체 활동, 인지 기능 등의 광범위한 데이터를 수집할 수 있습니다. 이러한 데이터는 GPS, 가속도계, 마이크와 같은 다양한 센서를 통해 수집되고 고급 알고리즘과 머신러닝 기술을 사용하여 분석됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
34억 9,000만 달러
시장 규모 : 2030년
80억 4,000만 달러
CAGR : 2025-2030년
14.88%
급성장 부문
생명공학 및 제약 회사
최대 시장
북미
디지털 바이오마커는 사실에 기반한 임상적으로 가치 있는 데이터를 수집할 수 있는 기회를 제공합니다. 필수적인 이미지 처리 능력과 공간 정밀도 향상에 기여합니다. 디지털 바이오마커는 경동맥 도관 질환, 위 대동맥류, 복잡한 프린지 정맥 질환, 대동맥 분석 등의 서비스를 제공합니다. 헬스케어 분야에서 디지털 바이오마커는 빅데이터 발견의 1차 출처입니다. 이들은 현재 건강 문제를 평가할 뿐만 아니라 위험한 시나리오를 예측하고 평가하는 데에도 도움이 됩니다. 이 장치는 내장형, 휴대용, 소모품, 착용형으로 사용할 수 있습니다. 질병의 조기 발견과 진단, 개인화된 치료, 삶의 질 향상을 가능하게 함으로써, 디지털 바이오마커의 응용은 의료 분야에 변화를 가져옵니다. 또한 연구자들에게 추세와 패턴을 파악하기 위한 풍부한 정보를 제공하여 새로운 치료법과 치료법 개발을 촉진합니다. 게다가, 임상조사에서 객관적이고 최소한의 환자 참여로 데이터를 얻음으로써 신빙성을 높일 수 있어 보다 정확한 의약품의 생산으로 이어집니다.
주요 시장 성장 촉진요인
암 유병률 상승
주요 시장 과제
높은 제품 비용
주요 시장 동향
디지털 바이오마커 사용 확대 및 웨어러블 디바이스 및 스마트폰의 보급
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 디지털 바이오마커 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
구성 요소별(데이터 수집 도구 대 데이터 통합 시스템)
유형별(신규 디지털 바이오 마커, 오리지널 디지털 바이오 마커, 승인된 디지털 바이오 마커)
치료 영역별(심혈관 질환, 수면 및 운동 질환, 신경 퇴행성 질환, 정신 질환, 기타)
최종 사용자별(생명공학 및 제약 회사, 지불자, 제공업체, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 디지털 바이오마커 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 디지털 바이오마커 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 디지털 바이오마커 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 디지털 바이오마커 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 디지털 바이오마커 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 세계의 디지털 바이오마커 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
ActiGraph, LLC
AliveCor, Inc.
Altoida AG
Biogen Inc.
Fitbit, Inc.
HumanAPI Inc.
Pfizer, Inc.
Sanofi SA
Novartis International AG
Neurotrack Technologies, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Digital Biomarkers Market was valued at USD 3.49 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 14.88% through 2030. Digital biomarkers capture information that individuals actively gather about their own well-being or the treatment of a condition using digital health technology. This information is used to explain, influence, and predict health outcomes. Digital biomarkers can collect extensive data, including sleep patterns, heart rate variability, physical activity, and cognitive function. They are collected through various sensors, such as GPS, accelerometers, and microphones, and analyzed using advanced algorithms and machine learning techniques.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.49 Billion
Market Size 2030
USD 8.04 Billion
CAGR 2025-2030
14.88%
Fastest Growing Segment
Biotechnology & Pharmaceutical Companies
Largest Market
North America
Digital biomarkers provide an opportunity to gather factual and clinically valuable data. They contribute to essential imaging capabilities and improved spatial accuracy. Digital biomarkers offer services for carotid conduit disease, stomach aortic aneurysm, complicated fringe vein disease, and aortic analysis. In the healthcare sector, digital biomarkers are the primary source of big data findings. They help evaluate current health issues, as well as predict and assess dangerous scenarios. These devices are available as implanted, portable, consumable, and wearable items. By enabling early disease identification and diagnosis, individualized therapies, and enhancing the quality of life, the application of digital biomarkers can transform the healthcare sector. Additionally, they provide researchers with a wealth of information to identify trends and patterns, facilitating the development of novel cures and treatments. Furthermore, the objective and minimally patient-involved data acquisition in clinical studies can enhance authenticity, leading to the production of more precise medications.
Key Market Drivers
Rise in Prevalence of Cancers
The worldwide pervasiveness of smoking, physical inactivity, and unhealthy food habits significantly influences the incidence of cancer. These habits, when combined, create an environment that promotes the development and progression of cancerous cells within the body. To this end, biomarkers play a crucial role in enabling constant tracking and monitoring of diverse characteristics regarding health and diseases. By measuring specific molecules or genetic alterations, biomarkers provide valuable insights into the underlying mechanisms of cancer development.
The multistage carcinogenesis process involves a series of molecular pathway events that eventually lead to the development of cancer. From the initial genetic mutations to the formation of a tumor, each step in this process contributes to the progression of the disease. Understanding these molecular events is essential for early detection, accurate diagnosis, and effective treatment of cancer. However, the diagnosis, prognosis, and therapy of cancer can be quite complex. Each cancer type differs from other forms based on its unique molecular profile, making it challenging to develop standardized approaches for treatment. This complexity necessitates the need for advanced technologies and innovative solutions to deliver personalized and precise care to patients.
In recent years, the concept of digital biomarkers has emerged as a promising avenue for better analysis and insights into patients' health. These digital biomarkers, collected through various digital health technologies such as wearable devices and mobile applications, provide continuous monitoring of individuals' health parameters. By capturing real-time data on vital signs, physical activity, sleep patterns, and other relevant indicators, digital biomarkers offer a comprehensive view of an individual's health status.
The increasing demand for personalized medicine and the growing adoption of digital health technologies have fueled the growth of the global digital biomarkers market. With the ability to provide objective and quantifiable data, digital biomarkers have opened up numerous opportunities for improving disease management and enhancing patient outcomes. This, in turn, has led to abundant growth in the field, with researchers, healthcare providers, and technology companies actively exploring the potential of digital biomarkers in transforming the future of healthcare.
Key Market Challenges
High Product Cost
The emerging field of digital biomarkers holds great promise for revolutionizing healthcare by providing valuable insights into patients' health and facilitating early disease detection. However, a significant obstacle to the widespread adoption of digital biomarkers is the high product cost associated with their development and implementation. This cost factor poses several challenges to the demand for digital biomarkers in healthcare. The high product cost of digital biomarkers affects their affordability for both healthcare providers and patients. The research, development, and validation processes for digital biomarkers involve substantial investments in technology, data collection, analytics, and regulatory compliance. These costs can translate into expensive licensing fees for healthcare institutions, limiting their ability to integrate these biomarkers into routine patient care.
The financial burden of high-cost digital biomarkers may deter healthcare organizations from investing in the necessary infrastructure and training required for their implementation. Smaller or underfunded healthcare facilities, in particular, may struggle to allocate resources to adopt these advanced technologies, leading to disparities in access to cutting-edge healthcare solutions. Additionally, the high product cost of digital biomarkers may result in higher healthcare expenses for patients. As the cost of implementing and utilizing these biomarkers is passed on to consumers, it could potentially discourage individuals from seeking out and utilizing these technologies, particularly in regions with limited healthcare coverage or insurance.
Key Market Trends
Growing Use of Digital Biomarkers and Penetration of Wearable Devices and Smartphones
The growing utilization of digital biomarkers in diabetes, respiratory diseases, cardiovascular diseases, and sleep disorders serves as a significant driver in the market. The adoption of handheld and wearable digital devices, which constitute a substantial portion of the digital biomarker market, has been facilitated by digital technologies. Health informatics is expanding the global market for digital biomarkers, enabling personalized and cost-effective care. Furthermore, the rapid evolution of telecommunications and IT infrastructure is fueling the demand for digital biomarkers. With increasing investments in healthcare digitalization and smart hospitals by governments and corporations, the global demand for digital biomarkers is expected to witness a boost.
Wearable devices, following Bluetooth headsets, rank as the industry's second-largest innovation. In healthcare, devices such as Google Glass, Apple Watch, Fitbit, MotivRing, and Oculus Rift are widely used. The growing prevalence of wearable devices in healthcare can be attributed to the rising global health awareness, increasing patient population, and the integration of technology into daily life. Numerous apps available on Google Play and iOS platforms monitor sleep, heart rate, and movement. A recent survey revealed that smartphones are utilized in 80% of developed countries and 82% of developing countries.
Key Market Players
ActiGraph, LLC
AliveCor, Inc.
Altoida AG
Biogen Inc.
Fitbit, Inc.
HumanAPI Inc.
Pfizer, Inc.
Sanofi S.A.
Novartis International AG
Neurotrack Technologies, Inc.
Report Scope:
In this report, the Global Digital Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Digital Biomarkers Market, By Component:
Data Collection Tools
Digital Platforms
Mobile Apps
Desktop-Based Software
Wearable
Others
Data Integration Systems
Digital Biomarkers Market, By Type:
Novel Digital Biomarkers
Original Digital Biomarkers
Approved Digital Biomarkers
Digital Biomarkers Market, By Therapeutic Area:
Cardiovascular Diseases
Sleep & Movement Diseases
Neurodegenerative Disorders
Psychiatric Disorder
Others
Digital Biomarkers Market, By End User:
Biotechnology & Pharmaceutical Companies
Payers
Providers
Others
Digital Biomarkers Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Digital Biomarkers Market.
Available Customizations:
Global Digital Biomarkers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Digital Biomarkers Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Data Collection Tools v/s Data Integration Systems)
5.2.1.1. Data Collection Tools {Digital Platforms, Mobile Apps, Desktop-Based Software, Wearable, Others}
5.2.2. By Type (Novel Digital Biomarkers, Original Digital Biomarkers, Approved Digital Biomarkers)
5.2.3. By Therapeutic Area (Cardiovascular Diseases, Sleep & Movement Diseases, Neurodegenerative Disorders, Psychiatric Disorder, Others)
5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Payers, Providers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Digital Biomarkers Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Type
6.2.3. By Therapeutic Area
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Digital Biomarkers Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Type
6.3.1.2.3. By Therapeutic Area
6.3.1.2.4. By End User
6.3.2. Canada Digital Biomarkers Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Type
6.3.2.2.3. By Therapeutic Area
6.3.2.2.4. By End User
6.3.3. Mexico Digital Biomarkers Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Type
6.3.3.2.3. By Therapeutic Area
6.3.3.2.4. By End User
7. Europe Digital Biomarkers Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Type
7.2.3. By Therapeutic Area
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Digital Biomarkers Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Type
7.3.1.2.3. By Therapeutic Area
7.3.1.2.4. By End User
7.3.2. United Kingdom Digital Biomarkers Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Type
7.3.2.2.3. By Therapeutic Area
7.3.2.2.4. By End User
7.3.3. Italy Digital Biomarkers Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Type
7.3.3.2.3. By Therapeutic Area
7.3.3.2.4. By End User
7.3.4. France Digital Biomarkers Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Type
7.3.4.2.3. By Therapeutic Area
7.3.4.2.4. By End User
7.3.5. Spain Digital Biomarkers Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Type
7.3.5.2.3. By Therapeutic Area
7.3.5.2.4. By End User
8. Asia-Pacific Digital Biomarkers Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Type
8.2.3. By Therapeutic Area
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Digital Biomarkers Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Type
8.3.1.2.3. By Therapeutic Area
8.3.1.2.4. By End User
8.3.2. India Digital Biomarkers Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Type
8.3.2.2.3. By Therapeutic Area
8.3.2.2.4. By End User
8.3.3. Japan Digital Biomarkers Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Type
8.3.3.2.3. By Therapeutic Area
8.3.3.2.4. By End User
8.3.4. South Korea Digital Biomarkers Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Type
8.3.4.2.3. By Therapeutic Area
8.3.4.2.4. By End User
8.3.5. Australia Digital Biomarkers Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Type
8.3.5.2.3. By Therapeutic Area
8.3.5.2.4. By End User
9. South America Digital Biomarkers Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Type
9.2.3. By Therapeutic Area
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital Biomarkers Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Type
9.3.1.2.3. By Therapeutic Area
9.3.1.2.4. By End User
9.3.2. Argentina Digital Biomarkers Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Type
9.3.2.2.3. By Therapeutic Area
9.3.2.2.4. By End User
9.3.3. Colombia Digital Biomarkers Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Type
9.3.3.2.3. By Therapeutic Area
9.3.3.2.4. By End User
10. Middle East and Africa Digital Biomarkers Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Type
10.2.3. By Therapeutic Area
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital Biomarkers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Type
10.3.1.2.3. By Therapeutic Area
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Digital Biomarkers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Type
10.3.2.2.3. By Therapeutic Area
10.3.2.2.4. By End User
10.3.3. UAE Digital Biomarkers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Type
10.3.3.2.3. By Therapeutic Area
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Digital Biomarkers Market: SWOT Analysis
